1. Home
  2. PPSI vs IOBT Comparison

PPSI vs IOBT Comparison

Compare PPSI & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pioneer Power Solutions Inc.

PPSI

Pioneer Power Solutions Inc.

HOLD

Current Price

$3.51

Market Cap

36.3M

Sector

Industrials

ML Signal

HOLD

Logo IO Biotech Inc.

IOBT

IO Biotech Inc.

HOLD

Current Price

$0.18

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPSI
IOBT
Founded
2008
2014
Country
United States
Denmark
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
26.6M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
PPSI
IOBT
Price
$3.51
$0.18
Analyst Decision
Strong Buy
Hold
Analyst Count
1
4
Target Price
$12.00
$2.25
AVG Volume (30 Days)
74.4K
1.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
1626.32
26.77
EPS
N/A
N/A
Revenue
$22,879,000.00
N/A
Revenue This Year
$26.84
N/A
Revenue Next Year
$10.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.26
$0.14
52 Week High
$5.70
$2.79

Technical Indicators

Market Signals
Indicator
PPSI
IOBT
Relative Strength Index (RSI) 42.86 23.53
Support Level $3.25 N/A
Resistance Level $4.05 $0.40
Average True Range (ATR) 0.22 0.03
MACD 0.01 -0.01
Stochastic Oscillator 33.02 13.85

Price Performance

Historical Comparison
PPSI
IOBT

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: